• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

下咽癌患者的第二原发性恶性肿瘤:一项基于监测、流行病学和最终结果(SEER)数据库的研究

Second Primary Malignancy in Patients with Hypopharyngeal Carcinoma: A SEER-Based Study.

作者信息

Guo Liqing, Fu Yanpeng, Miao Chunyu, Wu Shuhong, Zhu Yaqiong, Liu Yuehui

机构信息

Department of Otolaryngology, The Second Affiliated Hospital of Nanchang University, NanChang, 330006, JiangXi, People's Republic of China.

Department of Otolaryngology, Nanchang Affiliated Hospital of Sun Yat-Sen University, NanChang, 330009, JiangXi, People's Republic of China.

出版信息

Int J Gen Med. 2021 Nov 25;14:8847-8861. doi: 10.2147/IJGM.S339595. eCollection 2021.

DOI:10.2147/IJGM.S339595
PMID:34858052
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8630468/
Abstract

BACKGROUND

A population-based analysis of the risk of secondary primary malignancy (SPM) in patients with hypopharyngeal carcinoma (HPC) has been lacking in the literature. Therefore, we conducted this study to determine the risk factors and assess the effects of SPM on the overall survival (OS) and cancer-specific survival (CSS) of patients with HPC.

METHODS

Data on selected patients diagnosed with HPC from the Surveillance, Epidemiology and End Results (SEER) database between 1973 and 2015 were examined through logistic regression, Cox regression and nomogram methods.

RESULTS

The overall risk of SPM in patients with HPC was higher than that in the general population (SIR: 2.77; P < 0.05). The specific-site, including the oral cavity, pharynx, digestive system, respiratory system and endocrine system, had a relatively higher risk of SPM. The overall risks of the subgroup of people 55-75 years of age and all subgroups of sex, race and latency were significantly elevated. In addition, patients with HPC were more likely to have been diagnosed in 2010-2015 (vs 2004-2009; P = 0.002), to be unmarried (vs married; P = 0.008), to have distant metastasis (vs no metastasis; P = 0.016) and to have had no surgery for the first tumor (vs surgery for the first tumor; P = 0.021), and these aspects were associated with a significantly elevated risk of developing SPM. SPM was independently associated with better OS and CSS. The OS and CSS in patients with HPC with SPM were better than those in patients without SPM (log rank P < 0.0001). The C indexes of the nomogram constructed with ten influencing factors including SPM were 0.681:0.699 for OS and 0.705:0.724 for CSS (training cohort:validation cohort).

CONCLUSION

Although the overall risk of SPM in patients with HPC was elevated, SPM did not decrease the OS and CSS in patients with HPC. This finding is inconsistent with clinical observations and thus requires further research and exploration. It possibly because HPC might have a shorter survival time, or the follow-up time was not long enough.

摘要

背景

下咽癌(HPC)患者发生第二原发性恶性肿瘤(SPM)风险的基于人群的分析在文献中尚属空白。因此,我们开展本研究以确定风险因素,并评估SPM对HPC患者总生存期(OS)和癌症特异性生存期(CSS)的影响。

方法

通过逻辑回归、Cox回归和列线图方法,对1973年至2015年间监测、流行病学和最终结果(SEER)数据库中确诊为HPC的选定患者的数据进行分析。

结果

HPC患者发生SPM的总体风险高于一般人群(标准化发病比:2.77;P<0.05)。特定部位,包括口腔、咽、消化系统、呼吸系统和内分泌系统,发生SPM的风险相对较高。55 - 75岁人群亚组以及所有性别、种族和潜伏期亚组的总体风险均显著升高。此外,HPC患者更有可能在2010 - 2015年被诊断(vs 2004 - 2009年;P = 0.002)、未婚(vs已婚;P = 0.008)、有远处转移(vs无转移;P = 0.016)以及未对原发肿瘤进行手术(vs对原发肿瘤进行手术;P = 0.021),而这些方面与发生SPM的风险显著升高相关。SPM与更好的OS和CSS独立相关。发生SPM的HPC患者的OS和CSS优于未发生SPM的患者(对数秩检验P<0.0001)。由包括SPM在内十个影响因素构建的列线图,OS的C指数在训练队列:验证队列为0.681:0.699,CSS为0.705:0.724。

结论

尽管HPC患者发生SPM的总体风险升高,但SPM并未降低HPC患者的OS和CSS。这一发现与临床观察结果不一致,因此需要进一步研究和探索。这可能是因为HPC的生存时间可能较短,或者随访时间不够长。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7901/8630468/d9dd5a2a9630/IJGM-14-8847-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7901/8630468/49a9fbc11114/IJGM-14-8847-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7901/8630468/ea844a2c0b66/IJGM-14-8847-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7901/8630468/b9dab40a93a2/IJGM-14-8847-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7901/8630468/1dab40e13cbe/IJGM-14-8847-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7901/8630468/d9dd5a2a9630/IJGM-14-8847-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7901/8630468/49a9fbc11114/IJGM-14-8847-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7901/8630468/ea844a2c0b66/IJGM-14-8847-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7901/8630468/b9dab40a93a2/IJGM-14-8847-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7901/8630468/1dab40e13cbe/IJGM-14-8847-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7901/8630468/d9dd5a2a9630/IJGM-14-8847-g0005.jpg

相似文献

1
Second Primary Malignancy in Patients with Hypopharyngeal Carcinoma: A SEER-Based Study.下咽癌患者的第二原发性恶性肿瘤:一项基于监测、流行病学和最终结果(SEER)数据库的研究
Int J Gen Med. 2021 Nov 25;14:8847-8861. doi: 10.2147/IJGM.S339595. eCollection 2021.
2
Second primary malignancy in patients with cholangiocarcinoma: a population-based study.胆管癌患者的第二原发性恶性肿瘤:一项基于人群的研究。
Cancer Manag Res. 2019 Mar 1;11:1969-1983. doi: 10.2147/CMAR.S187614. eCollection 2019.
3
A nomogram for overall survival of second primary cancers following upper-tract urothelial carcinoma: a SEER population-based study.上尿路尿路上皮癌继发第二原发性癌症总生存的列线图:一项基于监测、流行病学和最终结果(SEER)数据库人群的研究
Transl Cancer Res. 2024 Aug 31;13(8):4131-4145. doi: 10.21037/tcr-24-515. Epub 2024 Aug 12.
4
Increased incidence of second primary malignancy in patients with malignant astrocytoma: a population-based study.恶性星形细胞瘤患者中第二原发性恶性肿瘤的发病率增加:一项基于人群的研究。
Biosci Rep. 2019 Jun 14;39(6). doi: 10.1042/BSR20181968. Print 2019 Jun 28.
5
Prognostic factors, treatment decisions, and nomograms for patients with second primary lung cancer following colorectal cancer: a population-based study.结直肠癌后发生第二原发性肺癌患者的预后因素、治疗决策及列线图:一项基于人群的研究
Updates Surg. 2023 Oct;75(7):1827-1842. doi: 10.1007/s13304-023-01605-5. Epub 2023 Aug 3.
6
The impact of age at the time of radiotherapy for localized prostate cancer on the development of second primary malignancies.局限性前列腺癌放疗时的年龄对第二原发性恶性肿瘤发生的影响。
Urol Oncol. 2018 Nov;36(11):500.e11-500.e19. doi: 10.1016/j.urolonc.2018.06.007. Epub 2018 Sep 21.
7
The risk and prognosis of secondary primary malignancy in lung cancer: a population-based study.肺癌中继发原发性恶性肿瘤的风险和预后:一项基于人群的研究。
Future Oncol. 2021 Nov;17(33):4497-4509. doi: 10.2217/fon-2021-0045. Epub 2021 Aug 17.
8
A Prognostic Model for Patients With Gastric Signet Ring Cell Carcinoma.胃印戒细胞癌患者的预后模型。
Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211027912. doi: 10.1177/15330338211027912.
9
A Clinical Model of Bone Angiosarcoma Patients: A Population-based Analysis of Epidemiology, Prognosis, and Treatment.骨血管肉瘤患者的临床模型:基于人群的流行病学、预后和治疗分析。
Orthop Surg. 2020 Dec;12(6):1652-1662. doi: 10.1111/os.12803. Epub 2020 Sep 10.
10
Impact of latency time on survival for adolescents and young adults with a second primary malignancy.潜伏期时间对青少年和年轻成人第二原发恶性肿瘤生存的影响。
Cancer. 2018 Mar 15;124(6):1260-1268. doi: 10.1002/cncr.31170. Epub 2017 Dec 4.

引用本文的文献

1
Factors associated with the development of second primary tumours in head and neck cancer patients.与头颈部癌症患者第二原发肿瘤发展相关的因素。
Eur J Cancer Care (Engl). 2022 Nov;31(6):e13699. doi: 10.1111/ecc.13699. Epub 2022 Sep 18.
2
A Proposed Link Between Acute Thymic Involution and Late Adverse Effects of Chemotherapy.急性胸腺萎缩与化疗后晚期不良反应之间的关联。
Front Immunol. 2022 Jul 1;13:933547. doi: 10.3389/fimmu.2022.933547. eCollection 2022.

本文引用的文献

1
Development and Validation of a Prognostic Nomogram for Hypopharyngeal Carcinoma.下咽癌预后列线图的开发与验证
Front Oncol. 2021 Jun 21;11:696952. doi: 10.3389/fonc.2021.696952. eCollection 2021.
2
Prognostic imaging variables for recurrent laryngeal and hypopharyngeal carcinoma treated with primary chemoradiotherapy: A systematic review and meta-analysis.接受原发性放化疗的复发性喉癌和下咽癌的预后影像变量:一项系统评价和荟萃分析。
Head Neck. 2021 Jul;43(7):2202-2215. doi: 10.1002/hed.26698. Epub 2021 Apr 2.
3
Survival analysis of second primary malignancies after cervical cancer using a competing risk model: implications for prevention and surveillance.
使用竞争风险模型对宫颈癌后第二原发性恶性肿瘤进行生存分析:对预防和监测的意义
Ann Transl Med. 2021 Feb;9(3):239. doi: 10.21037/atm-20-2003.
4
A novel prognostic model predicting the long-term cancer-specific survival for patients with hypopharyngeal squamous cell carcinoma.一种预测下咽鳞癌患者长期癌症特异性生存的新型预后模型。
BMC Cancer. 2020 Nov 11;20(1):1095. doi: 10.1186/s12885-020-07599-2.
5
Selected CDKN2A and MDM2 polymorphisms in oral cavity cancer.口腔癌中 CDKN2A 和 MDM2 多态性的选择。
Acta Biochim Pol. 2020 May 7;67(2):213-218. doi: 10.18388/abp.2020_5195.
6
Cancer statistics, 2020.癌症统计数据,2020 年。
CA Cancer J Clin. 2020 Jan;70(1):7-30. doi: 10.3322/caac.21590. Epub 2020 Jan 8.
7
Artificial intelligence in cancer diagnosis and prognosis: Opportunities and challenges.人工智能在癌症诊断和预后中的应用:机遇与挑战。
Cancer Lett. 2020 Feb 28;471:61-71. doi: 10.1016/j.canlet.2019.12.007. Epub 2019 Dec 10.
8
Personalizing prostate cancer diagnosis with multivariate risk prediction tools: how should prostate MRI be incorporated?利用多变量风险预测工具实现前列腺癌个体化诊断:应如何纳入前列腺 MRI?
World J Urol. 2020 Mar;38(3):531-545. doi: 10.1007/s00345-019-02899-0. Epub 2019 Aug 9.
9
The changing therapeutic landscape of head and neck cancer.头颈部癌症治疗领域的变化。
Nat Rev Clin Oncol. 2019 Nov;16(11):669-683. doi: 10.1038/s41571-019-0227-z. Epub 2019 Jun 12.
10
Increased incidence of second primary malignancy in patients with malignant astrocytoma: a population-based study.恶性星形细胞瘤患者中第二原发性恶性肿瘤的发病率增加:一项基于人群的研究。
Biosci Rep. 2019 Jun 14;39(6). doi: 10.1042/BSR20181968. Print 2019 Jun 28.